Abstract
Pathogen recognition by Toll-like receptors (TLRs) initiates innate immune responses that are essential for inhibiting pathogen dissemination and for the development of acquired immunity. The TLRs recognize pathogens with their N-terminal ectodomains (ECD), but the molecular basis for this recognition is not known. Recently we reported the x-ray structure for unliganded TLR3-ECD; however, it has proven difficult to obtain a crystal structure of TLR3 with its ligand, dsRNA. We have now located the TLR3 ligand binding site by mutational analysis. More than 50 single-residue mutations have been generated throughout the TLR3-ECD, but only two, H539E and N541A, resulted in the loss of TLR3 activation and ligand binding functions. These mutations locate the dsRNA binding site on the glycan-free, lateral surface of TLR3 toward the C terminus and suggest a model for dsRNA binding and TLR3 activation.
MeSH Terms
Binding Sites
Humans
Leucine-Rich Repeat Proteins
Ligands
Models, Molecular
Mutation/genetics
Nucleic Acid Conformation
Protein Conformation
Proteins/genetics
RNA, Double-Stranded/chemistry,genetics,metabolism
RNA-Binding Proteins/chemistry,genetics,metabolism
Signal Transduction
Sulfates/metabolism
Toll-Like Receptor 3/chemistry,genetics,metabolism
Chemicals
Leucine-Rich Repeat Proteins
Ligands
Proteins
RNA, Double-Stranded
RNA-Binding Proteins
Sulfates
Toll-Like Receptor 3
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bell Jessica K
Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, and Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Askins Janine
Hall Pamela R
Davies David R
Segal David M
References (27)
27 references, click to expand
-
TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells.
J Immunol. 2004 Jul 1;173(1):531-41
PMID: 15210814
-
APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
J Immunol. 2004 Jan 1;172(1):138-43
PMID: 14688319
-
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10116-21
PMID: 15218108
-
Four N-linked glycosylation sites in human toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion.
J Biol Chem. 2004 Aug 13;279(33):34589-94
PMID: 15173186
-
A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4.
J Biol Chem. 2004 Aug 13;279(33):34698-704
PMID: 15175334
-
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science. 1998 Dec 11;282(5396):2085-8
PMID: 9851930
-
Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA.
EMBO J. 1998 Dec 15;17(24):7505-13
PMID: 9857205
-
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
J Exp Med. 1999 Jun 7;189(11):1777-82
PMID: 10359581
-
p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells.
Blood. 2004 Dec 15;104(13):4157-64
PMID: 15315972
-
The double-stranded RNA-binding motif, a versatile macromolecular docking platform.
FEBS J. 2005 May;272(9):2109-17
PMID: 15853796
-
Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.
Science. 2005 Jul 22;309(5734):581-5
PMID: 15961631
-
The molecular structure of the Toll-like receptor 3 ligand-binding domain.
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10976-80
PMID: 16043704
-
TLR3 in antiviral immunity: key player or bystander?
Trends Immunol. 2005 Sep;26(9):462-8
PMID: 16027039
-
Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.
J Biol Chem. 2005 Nov 18;280(46):38133-45
PMID: 16144834
-
Pathogen recognition and innate immunity.
Cell. 2006 Feb 24;124(4):783-801
PMID: 16497588
-
Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation.
J Biol Chem. 2006 Apr 21;281(16):11144-51
PMID: 16533755
-
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
Nature. 2000 Nov 2;408(6808):111-5
PMID: 11081518
-
Regulation of Toll-like receptors in human monocytes and dendritic cells.
J Immunol. 2001 Jan 1;166(1):249-55
PMID: 11123299
-
Intracellular functions of N-linked glycans.
Science. 2001 Mar 23;291(5512):2364-9
PMID: 11269317
-
How the immune system works to protect the host from infection: a personal view.
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7461-8
PMID: 11390983
-
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Nature. 2001 Oct 18;413(6857):732-8
PMID: 11607032
-
Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
Biochem Biophys Res Commun. 2002 May 24;293(5):1364-9
PMID: 12054664
-
An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.
Biochem Biophys Res Commun. 2002 Nov 29;299(2):216-21
PMID: 12437972
-
The role of disulfide bonds in the assembly and function of MD-2.
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3919-24
PMID: 12642668
-
Subcellular localization of Toll-like receptor 3 in human dendritic cells.
J Immunol. 2003 Sep 15;171(6):3154-62
PMID: 12960343
-
Leucine-rich repeats and pathogen recognition in Toll-like receptors.
Trends Immunol. 2003 Oct;24(10):528-33
PMID: 14552836
-
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
J Allergy Clin Immunol. 2004 Jul;114(1):174-82
PMID: 15241362